Clinical trial
Study Evaluating the Effect of TC-6499 on Gastric Emptying Time in Diabetic Subjects With Gastroparesis
NCT02187094 is registered in ClinicalTrials.gov with Targacept Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study Evaluating the Effect of TC-6499 on Gastric Emptying Time in Diabetic Subjects With Gastroparesis
- Lead sponsor
- Targacept Inc.
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- June 30, 2014
- Completion date
- January 31, 2015
- Enrollment
- 80 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.